FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$4.35Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $201,512,000.00
EPSttm : -3.18
4D Molecular Therapeutics, Inc.
$4.35
11.25%$0.44Float Short %
11.24
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
-0.08
EPS Last/This Y
-0.58
EPS This/Next Y
-0.32
Price
4.35
Target Price
29.56
Analyst Recom
1.82
Performance Q
6.88
Relative Volume
1.1
Beta
2.82
Ticker: FDMT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | FDMT | 3.23 | 0.22 | 0.00 | 3937 |
| 2025-05-09 | FDMT | 3.09 | 0.22 | 0.00 | 3967 |
| 2025-05-12 | FDMT | 3.31 | 0.22 | 0.00 | 3959 |
| 2025-05-13 | FDMT | 3.26 | 0.22 | 0.00 | 3988 |
| 2025-05-14 | FDMT | 3.14 | 0.22 | 2.31 | 4008 |
| 2025-05-15 | FDMT | 3.19 | 0.22 | 2.31 | 4008 |
| 2025-05-16 | FDMT | 3.45 | 0.23 | 0.00 | 4074 |
| 2025-05-19 | FDMT | 3.78 | 0.13 | 0.16 | 3749 |
| 2025-05-20 | FDMT | 3.84 | 0.13 | 0.00 | 3838 |
| 2025-05-21 | FDMT | 3.55 | 0.13 | 50.00 | 3909 |
| 2025-05-22 | FDMT | 3.61 | 0.13 | 50.00 | 3909 |
| 2025-05-23 | FDMT | 3.5 | 0.18 | 0.00 | 4113 |
| 2025-05-27 | FDMT | 3.42 | 0.18 | 1.70 | 4125 |
| 2025-05-28 | FDMT | 3.49 | 0.18 | 0.00 | 4141 |
| 2025-05-29 | FDMT | 3.71 | 0.18 | 0.00 | 4151 |
| 2025-05-30 | FDMT | 3.62 | 0.18 | 0.00 | 4151 |
| 2025-06-02 | FDMT | 3.74 | 0.17 | 0.00 | 4211 |
| 2025-06-03 | FDMT | 3.87 | 0.17 | 0.00 | 4211 |
| 2025-06-04 | FDMT | 3.83 | 0.17 | 0.00 | 4239 |
| 2025-06-05 | FDMT | 3.9 | 0.17 | 0.00 | 4268 |
| 2025-06-06 | FDMT | 4.34 | 0.17 | 0.03 | 4290 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | FDMT | 3.24 | -30.6 | - | -3.57 |
| 2025-05-09 | FDMT | 3.08 | -30.6 | - | -3.57 |
| 2025-05-12 | FDMT | 3.32 | -30.6 | - | -3.57 |
| 2025-05-13 | FDMT | 3.27 | -30.6 | - | -3.57 |
| 2025-05-14 | FDMT | 3.13 | -30.6 | - | -3.57 |
| 2025-05-15 | FDMT | 3.20 | -30.6 | - | -3.57 |
| 2025-05-16 | FDMT | 3.45 | -30.6 | - | -3.56 |
| 2025-05-19 | FDMT | 3.80 | -10.0 | - | -3.56 |
| 2025-05-20 | FDMT | 3.85 | -10.0 | - | -3.56 |
| 2025-05-21 | FDMT | 3.54 | -10.0 | - | -3.56 |
| 2025-05-22 | FDMT | 3.61 | -10.0 | - | -3.56 |
| 2025-05-23 | FDMT | 3.49 | -10.0 | - | -3.56 |
| 2025-05-27 | FDMT | 3.42 | -10.0 | - | -3.56 |
| 2025-05-28 | FDMT | 3.48 | -10.0 | - | -3.56 |
| 2025-05-29 | FDMT | 3.71 | -10.0 | - | -3.56 |
| 2025-05-30 | FDMT | 3.62 | -10.0 | - | -3.56 |
| 2025-06-02 | FDMT | 3.73 | -10.0 | - | -3.56 |
| 2025-06-03 | FDMT | 3.87 | -10.0 | - | -3.56 |
| 2025-06-04 | FDMT | 3.84 | -10.0 | - | -3.56 |
| 2025-06-05 | FDMT | 3.91 | -10.0 | - | -3.56 |
| 2025-06-06 | FDMT | 4.35 | -10.0 | - | -3.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | FDMT | 0.00 | -25.67 | 13.12 |
| 2025-05-09 | FDMT | 0.00 | -25.67 | 13.12 |
| 2025-05-12 | FDMT | 0.00 | -24.30 | 12.69 |
| 2025-05-13 | FDMT | 0.00 | -24.30 | 12.69 |
| 2025-05-14 | FDMT | 0.00 | -24.30 | 12.69 |
| 2025-05-15 | FDMT | 0.00 | -24.30 | 12.74 |
| 2025-05-16 | FDMT | 0.00 | -24.30 | 12.74 |
| 2025-05-19 | FDMT | 0.00 | -23.12 | 12.13 |
| 2025-05-20 | FDMT | 0.00 | -23.12 | 12.13 |
| 2025-05-21 | FDMT | 0.00 | -23.12 | 12.13 |
| 2025-05-22 | FDMT | 0.00 | -23.12 | 12.13 |
| 2025-05-23 | FDMT | 0.00 | -23.12 | 12.13 |
| 2025-05-27 | FDMT | 0.00 | -9.84 | 12.13 |
| 2025-05-28 | FDMT | 0.00 | -9.84 | 11.24 |
| 2025-05-29 | FDMT | 0.00 | -9.84 | 11.24 |
| 2025-05-30 | FDMT | 0.00 | -9.84 | 11.24 |
| 2025-06-02 | FDMT | 0.00 | -8.58 | 11.24 |
| 2025-06-03 | FDMT | 0.00 | -8.58 | 11.24 |
| 2025-06-04 | FDMT | 0.00 | -8.58 | 11.24 |
| 2025-06-05 | FDMT | 0.00 | -8.58 | 11.24 |
| 2025-06-06 | FDMT | 0.00 | -8.58 | 11.24 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.86
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.94
Insider Transactions
Institutional Transactions
-8.58
Beta
2.82
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
31
Sentiment Score
41
Actual DrawDown %
92.1
Max Drawdown 5-Year %
Target Price
29.56
P/E
Forward P/E
PEG
P/S
10075.65
P/B
0.43
P/Free Cash Flow
EPS
-3.37
Average EPS Est. Cur. Y
-3.56
EPS Next Y. (Est.)
-3.88
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
-767126.09
Relative Volume
1.1
Return on Equity vs Sector %
-61.6
Return on Equity vs Industry %
-43.6
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading